Across TCGA pan-cancer cohorts, RAB5C RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated RAB5C data layer compared with 5 for mutation status and 8 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher RAB5C RNA is associated with better overall survival. In most high-consensus cancer types, elevated RAB5C expression acts as an unfavorable survival marker, although some lineages such as COAD and SCLC show a favorable association.
COAD, MESO, and LIHC are the cancer types where RAB5C RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.